Association of Vitamin D, Parathyroid Hormone and Fibroblast Growth Factor-23 With Infarction-related Arrhythmia in Patients With Acute Myocardial Infarction

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01971619

Enrollment

510

Registered

2013-10-29

Start date

2013-08-31

Completion date

2015-08-31

Last updated

2013-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Brief summary

To investigate the effect of vitamin D deficiency on the development of arrhythmia in patients with acute myocardial infarction.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 90 Years

Healthy volunteers

Inclusion criteria

* age ≥20 years * diagnosed with acute myocardial infarction (confirmed by cardiac enzyme and EKG) * subjects who agreed with informed consent

Exclusion criteria

* previous history of arrhythmia before onset of acute myocardial infarction * currently taking anti-arrhythmic drugs * severe condition of comorbid diseases that can cause more serious effects on patients than acute myocardial infarction does (e.g., cancer, cerebrovascular diseases, acute bleeding etc.)

Design outcomes

Primary

Measure	Time frame	Description
Events of acute myocardial infarction-associated arrhythmia	first 48 hours after onset of acute myocardial infarction	incidence of acute myocardial infarction-associated arrhythmia types of arrhythmia, duration of arrhythmia, persistence of arrhythmia

Countries

South Korea

Contacts

Primary ContactJin Wi, MD

caesar@yuhs.ac82-2-2228-8429

Outcome results